MEFV and amyloidosis: On the other hand, in a series of secondary amyloidosis cases from France, 15.3% of the patients did not have any mutations in the MEFV gene or in other autoinflammatory disease (AID) genes, suggesting that unknown factors may contribute to the development of amyloidosis.